Pediatric obesity and vitamin D deficiency: A proteomic approach identifies multimeric adiponectin as a key link between these conditions

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Walker, Gillian E ^a   Ricotti, Roberta ^a   Roccio, Marta ^a   Moia, Stefania ^a   Bellone, Simonetta ^a   Prodam, Flavia ^a   Bona, Gianni ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ADIPONECTIN; CALCIFEDIOL; CALCITRIOL; COLECALCIFEROL; INSULIN;

ADIPOCYTE; ADOLESCENT; ADULT; ANIMAL CELL; ARTICLE; CHILD; CHILDHOOD OBESITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HUMAN; IMAGE ANALYSIS; IN VITRO STUDY; INSULIN SENSITIVITY; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROADIPOCYTE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ADOLESCENT; ANIMALS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHOLECALCIFEROL; FEMALE; HUMANS; MALE; MICE; PEDIATRIC OBESITY; PROTEIN MULTIMERIZATION; PROTEOMICS; VITAMIN D DEFICIENCY;

EID: 84896740823     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083685     Document Type: Article

References (58)

1. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357: 266-281.
2. Martini LA, Wood RJ (2006) Vitamin D status and the metabolic syndrome. Nutr Rev 64: 479-486. (Pubitemid 44808263)
3. Song Q, Sergeev IN (2012) Calcium and vitamin D in obesity. Nutr Res Rev 16: 1-12.
4. Weisse K, Winkler S, Hirche F, Herberth G, Hinz D, et al. (2013) Maternal and newborn vitamin D status and its impact on food allergy development in the german LINA cohort study. Eur J Allergy Clin Immunol 68: 220-228.
5. Ford ES, Ajani UA, McGuire LC, Liu S (2005) Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 28: 1228-1230. (Pubitemid 40616645)
6. Liu E, Meigs JB, Pittas AG, McKeown NM, Economos CD, et al. (2009) Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 139: 329-334.
7. Alvarez JA, Ashraf A (2010) Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol. 351385.
8. Thomas GN, Hartaigh B, Bosch JA, Pilz S, Loerbroks A, et al. (2012) Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Diabetes Care 35: 1158-1164.
9. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al. (2011) Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96: 1911-1930.
10. Reis JP, von Mühlen D, Miller ER 3rd, Michos ED, Appel LJ (2009) Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics 124: e371-379.
11. Zúñiga S, Firrincieli D, Housset C, Chignard N (2011) Vitamin D and the vitamin D receptor in liver pathophysiology. Clin Res Hepatol Gastroenterol 35: 295-302.
12. Sergeev IN (2009) Novel mediators of vitamin D signaling in cancer and obesity. Immun. Endoc. Metab. Agents Med. Chem 9: 153-158.
13. Wu-Wong JR (2009) Potential for vitamin D receptor agonists in the treatment of cardiovascular disease. Br J Pharmacol 158: 395-412.
14. Hyppönen E, Power C (2006) Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care 29: 2244-2246. (Pubitemid 44899859)
15. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, et al. (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96: 53-58.
16. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503-511.
17. Zhou P, Schechter C, Cai Z, Markowitz M (2011) Determinants of 25(OH)D sufficiency in obese minority children: selecting outcome measures and analytic approaches. J Pediatr. 158: 930-934.e1.
18. Oberbach A, Blüher M, Wirth H, Till H, Kovacs P, et al. (2011) Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J Proteome Res 10: 4769-4788.
19. Cacciari E, Milani S, Balsamo A, Spada E, Bona G, et al. (2006) Italian crosssectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 29: 581-593. (Pubitemid 44446267)
20. Wagner CL, Greer FR (2008) American Academy of Pediatrics Section on Breastfeeding; American Academy of Pediatrics Committee on Nutrition. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 122: 1142-1152.
21. Tanner JM, Whitehouse RH (1976) Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51: 170-179.
22. Prodam F, Trovato L, Demarchi I, Busti A, Petri A, et al. (2011) Unacylated, acylated ghrelin and obestatin levels are differently inhibited by oral glucose load in pediatric obesity: association with insulin sensitivity and metabolic alterations. e-SPEN, The European e-Journal of Clinical Nutrition and Metabolism 6: 109-115.
23. Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M, et al. (2010) Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med. 2:46ps42.
24. de Roos B, Duthie SJ, Polley AC, Mulholland F, Bouwman FG, et al. (2008) Proteomic methodological recommendations for studies involving human plasma, platelets, and peripheral blood mononuclear cells. J Proteome Res 7: 2280-2290.
25. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, et al. (2003) Structurefunction studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 278: 9073-9085. (Pubitemid 36800387)
26. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, et al. (2010) Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33: 920-922.
27. Lichtash CT, Cui J, Guo X, Chen YD, Hsueh WA, et al. (2013) Body Adiposity Index versus Body Mass Index and Other Anthropometric Traits as Correlates of Cardiometabolic Risk Factors. PLoS One 8: e65954.
28. Hillman JB, Tong J, Tschop M. (2011) Ghrelin biology and its role in weightrelated disorders. Discov Med 11: 521-528.
29. Liu M, Zhou L, Xu A, Lam KS, Wetzel MD, et al. (2008) A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization. Proc Natl Acad Sci USA 105: 18302-18307.
30. Wang ZV, Scherer PE (2008) DsbA-L is a versatile player in adiponectin secretion. Proc Natl Acad Sci USA 105: 18077-18078.
31. Kelly A, Brooks LJ, Dougherty S, Carlow DC, Zemel BS (2011) A crosssectional study of vitamin D and insulin resistance in children. Arch Dis Child 96: 447-452.
32. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72: 690-693. (Pubitemid 30667088)
33. Buffington C, Walker B, Cowan GS Jr, Scruggs D (1993) Vitamin D Deficiency in the Morbidly Obese. Obes Surg 3: 421-424.
34. Ashraf A, Alvarez J, Saenz K, Gower B, McCormick K, et al (2009) Threshold for effects of vitamin D deficiency on glucose metabolism in obese female African-American adolescents. J Clin Endocrinol Metab 94: 3200-3206.
35. Meerza D, Naseem I, Ahmed J (2012) Effect of 1, 25(OH)(2) vitamin D(3) on glucose homeostasis and DNA damage in type 2 diabetic mice. J Diabetes Complications 26: 363-368.
36. George PS, Pearson ER, Witham MD (2012) Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and metaanalysis. Diabet Med 29: e142-50.
37. Shetty S, Kusminski CM, Scherer PE (2009) Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. Trends Pharmacol Sci 30: 234-239.
38. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, et al. (2004) Adiponectin acts in the brain to decrease body weight. Nat Med 10: 524-529. (Pubitemid 38667912)
39. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, et al. (2005) Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK-and COX-2-dependent mechanisms. Nat Med 11: 1096-1103. (Pubitemid 41486832)
40. Sun X, Zemel MB (2007) Calcium and 1,25-dihydroxyvitamin D3 regulation of adipokine expression. Obesity (Silver Spring) 15: 340-348. (Pubitemid 46407314)
41. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270(45): 26746-26749.
42. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT (2006) Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55: 249-259. (Pubitemid 43343322)
43. Gueugnon C, Mougin F, Simon-Rigaud ML, Regnard J, Nègre V, et al. (2012) Effects of an in-patient treatment program based on regular exercise and a balanced diet on high molecular weight adiponectin, resistin levels, and insulin resistance in adolescents with severe obesity. Appl Physiol Nutr Metab. 37(4):672-679.
44. Martos-Moreno GÁ, Barrios V, Martínez G, Hawkins F, Argente J. (2010) Effect of weight loss on high-molecular weight adiponectin in obese children. Obesity (Silver Spring) 18(12):2288-2294.
45. Norman AW (2006) Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147: 5542-5548. (Pubitemid 44833469)
46. Kong J, Li YC (2006) Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab 290: E916-924.
47. Blumberg JM, Tzameli I, Astapova I, Lam FS, Flier JS, et al. (2006) Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells. J Biol Chem 281: 11205-11213. (Pubitemid 43855546)
48. Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, et al. (2007) Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 77: 47-57. (Pubitemid 46590467)
49. Lorente-Cebrián S, Eriksson A, Dunlop T, Mejhert N, Dahlman I, et al. (2012) Differential effects of 1a,25-dihydroxycholecalciferol on MCP-1 and adiponectin production in human white adipocytes. Eur J Nutr 51: 335-342.
50. Gao D, Trayhurn P, Bing C (2012) 1,25-Dihydroxyvitamin D(3) inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes. Int J Obes (Lond) doi: 10.1038/ijo.2012.53.
51. Walker GE, Marzullo P, Verti B, Guzzaloni G, Maestrini S, et al. (2008) Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects. Obesity (Silver Spring). 16: 1983-1991.
52. Zhou L, Liu M, Zhang J, Chen H, Dong LQ, et al. (2010) DsbA-L alleviates endoplasmic reticulum stress-induced adiponectin downregulation. Diabetes 59: 2809-2816.
53. Liu M, Liu F (2009) Transcriptional and post-translational regulation of adiponectin. Biochem J 425: 41-52.
54. Freedman DS, Wang J, Thornton JC, Mei Z, Sopher AB, et al. (2009) Classification of body fatness by body mass index-for-age categories among children. Arch Pediatr Adolesc Med. 163: 805-811.
55. Belenchia AM, Tosh AK, Hillman LS, Peterson CA. (2013) Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr. 97: 774-781.
56. Breslavsky A, Frand J, Matas Z, Boaz M, Barnea Z, et al. (2013) Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr. S0261-5614(13)00047-2.
57. Petta S, Amato MC, Di Marco V, Cammà C, Pizzolanti G, et al. (2012) Visceral adiposity index is associated with significant fibrosis in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther 35: 238-247.
58. Gupta GK, Agrawal T, DelCore MG, Mohiuddin SM, Agrawal DK. (2012) Vitamin D deficiency induces cardiac hypertrophy and inflammation in epicardial adipose tissue in hypercholesterolemic swine. Exp Mol Pathol. 93(1):82-90.